Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant

View ORCID ProfileP.-E. Morange, F. Peiretti, L. Gourhant, C. Proust, A-S Pulcrano-Nicolas, G.-V. Saripella, View ORCID ProfileL. Stefanucci, View ORCID ProfileR. Lacroix, M. -Ibrahim.Kosta, View ORCID ProfileC. Lemarié, View ORCID ProfileMattia Frontini, View ORCID ProfileM.-C. Alessi, D.-A. Trégouët, View ORCID ProfileF. Couturaud
doi: https://doi.org/10.1101/2020.05.23.20101402
P.-E. Morange
1Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France,
2Hematology laboratory, CHU Timone, Marseille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P.-E. Morange
  • For correspondence: pierre.morange@ap-hm.fr
F. Peiretti
1Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Gourhant
3EA3878-GETBO, Univ Brest, Department of internal medicine and chest diseases, FCRIN_INNOVTE, CHU Brest, Brest, France,
4INSERM U1078, Brest.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Proust
5Sorbonne Université, UPMC, INSERM UMR_S 1166, Paris, France
6INSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, France (current affiliation).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A-S Pulcrano-Nicolas
5Sorbonne Université, UPMC, INSERM UMR_S 1166, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.-V. Saripella
5Sorbonne Université, UPMC, INSERM UMR_S 1166, Paris, France
7SLU Bioinformatics Infrastructure (SLUBI), PlantLink,Department of Plant Breeding, Swedish University of Agricultural Sciences, Alnarp, Sweden (current affiliation)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Stefanucci
8National Institute for Health Research BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom
9NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom
10British Heart Foundation Centre of Excellence, Cambridge Biomedical Campus, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Stefanucci
R. Lacroix
1Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Lacroix
M. -Ibrahim.Kosta
1Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France,
2Hematology laboratory, CHU Timone, Marseille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Lemarié
3EA3878-GETBO, Univ Brest, Department of internal medicine and chest diseases, FCRIN_INNOVTE, CHU Brest, Brest, France,
4INSERM U1078, Brest.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Lemarié
Mattia Frontini
8National Institute for Health Research BioResource, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom
9NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom
10British Heart Foundation Centre of Excellence, Cambridge Biomedical Campus, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mattia Frontini
M.-C. Alessi
1Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France,
2Hematology laboratory, CHU Timone, Marseille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M.-C. Alessi
D.-A. Trégouët
5Sorbonne Université, UPMC, INSERM UMR_S 1166, Paris, France
6INSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, France (current affiliation).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Couturaud
3EA3878-GETBO, Univ Brest, Department of internal medicine and chest diseases, FCRIN_INNOVTE, CHU Brest, Brest, France,
4INSERM U1078, Brest.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Couturaud
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Rare variants outside the classical coagulation cascade might cause rare inherited thrombosis. We aimed to identify the variant(s) causing venous thromboembolism (VTE) in a family with multiple relatives affected with unprovoked VTE and no thrombophilia defects. We identified by whole exome sequencing an extremely rare Arg to Gln variant (R89Q) in the Microtubule Associated Serine/Threonine Kinase 2 (MAST2) gene that segregates with VTE in the family. Free-tissue factor pathway inhibitor (f-TFPI) plasma levels were significantly decreased in affected family members compared to healthy relatives. Conversely, plasminogen activator inhibitor-1 (PAI-1) levels were significantly higher in affected members than in healthy relatives. RNA sequencing analysis of RNA interference experimental data conducted in endothelial cells revealed that, of the 13,387 detected expressed genes, 2,354 have their level of expression modified by MAST2 knockdown, including SERPINE1 coding for PAI-1 and TFPI. In HEK293 cells overexpressing the MAST2R289Q variant, TFPI and SERPINE1 promoter activities were respectively lower and higher than in cells overexpressing the MAST2 wild type allele. This study identifies a novel thrombophilia-causing R89Q variant in the MAST2 gene that is here proposed as a new molecular player in the etiology of VTE by interfering with hemostatic balance of endothelial cells.

Author Summary Venous thromboembolism (VTE) is a multifactorial disease in which the genetic burden. We here present the case of a French family with multiple relatives affected with unprovoked VTE (i.e. that occurred in the absence of clinical risk factors) in which no thrombophilia defects had been identified. Adopting a whole exome sequencing approach, we identified an extremely rare variant located in the Microtubule-associated serine/threonine-protein kinase-2 (MAST2) gene that perfectly segregates with the VTE phenotype and that interferes with hemostatic balance of endothelial cells. Our results pave the way for adding MAST2 to the list of genes to be sequenced and looked for in thrombophilia families with unprovoked VTE.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

The study was not registered as it is not a clinical trial

Funding Statement

GV.S was financially supported by the GENMED Laboratory of Excellence on Medical Genomics [ANR-10-LABX-0013]. Sequencing was funded by the Fondation pour les Maladies Rares and was performed by the IGBMC Microarray and Sequencing platform, a member of the France Genomique consortium (ANR-10-INBS-0009). DA.T was financially supported by the EPIDEMIOM-VTE Senior Chair from the Initiative of Excellence of the University of Bordeaux. The NIHR BioResource-Rare Diseases projects were approved by Research Ethics Committees in the UK and appropriate national ethics authorities in non-UK enrolment centers. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support. We thank the Professor Sandset for the kind gift of the PGL3-TFPI promoter vector.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All family members signed a written informed consent for genetic investigations. The recruitment had approval from the Brest Ethic Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data in the manuscript are available upon request to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant
P.-E. Morange, F. Peiretti, L. Gourhant, C. Proust, A-S Pulcrano-Nicolas, G.-V. Saripella, L. Stefanucci, R. Lacroix, M. -Ibrahim.Kosta, C. Lemarié, Mattia Frontini, M.-C. Alessi, D.-A. Trégouët, F. Couturaud
medRxiv 2020.05.23.20101402; doi: https://doi.org/10.1101/2020.05.23.20101402
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant
P.-E. Morange, F. Peiretti, L. Gourhant, C. Proust, A-S Pulcrano-Nicolas, G.-V. Saripella, L. Stefanucci, R. Lacroix, M. -Ibrahim.Kosta, C. Lemarié, Mattia Frontini, M.-C. Alessi, D.-A. Trégouët, F. Couturaud
medRxiv 2020.05.23.20101402; doi: https://doi.org/10.1101/2020.05.23.20101402

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (450)
  • Dentistry and Oral Medicine (82)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5248)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (755)
  • Geriatric Medicine (80)
  • Health Economics (212)
  • Health Informatics (696)
  • Health Policy (356)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5849)
  • Intensive Care and Critical Care Medicine (358)
  • Medical Education (103)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (762)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (476)
  • Ophthalmology (150)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (140)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (860)
  • Public and Global Health (2004)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (283)
  • Rheumatology (94)
  • Sexual and Reproductive Health (73)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)